Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 10180Neoplasms 7807Carcinoma, Non-Small-Cell Lung 5756Prostatic Neoplasms 5024Colorectal Neoplasms 4603Lung Neoplasms 3723Leukemia, Myeloid, Acute 3102Neoplasm Metastasis 3082Multiple Myeloma 3081Pancreatic Neoplasms 2843Melanoma 2651Ovarian Neoplasms 2573Lymphoma 2570Carcinoma, Hepatocellular 2479Stomach Neoplasms 2329Recurrence 2229Head and Neck Neoplasms 2102Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Lymphoma, Non-Hodgkin 2057Leukemia 2013Brain Neoplasms 1902Glioblastoma 1795Colonic Neoplasms 1790Leukemia, Lymphocytic, Chronic, B-Cell 1771Rectal Neoplasms 1719Uterine Cervical Neoplasms 1693Squamous Cell Carcinoma of Head and Neck 1654Lymphoma, Follicular 1651Lymphoma, Large B-Cell, Diffuse 1597Carcinoma, Renal Cell 1577

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Hepatitis, Alcoholic × Clear all
NCT00116454 2026-04-03

Lipiocis

ANRS, Emerging Infectious Diseases

Phase 3 Completed
73 enrolled
Gastrointestinal

Hepatitis, Alcoholic, Hepatitis, Viral, Human, Carcinoma, Hepatocellular

NCT01452295 2013-12-04

Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion

Vital Therapies, Inc.

Phase 2/3 Withdrawn

Hepatitis, Alcoholic, Liver Failure, Liver Failure, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡